COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?

被引:8
|
作者
Dhabaan, Ghulam [1 ]
Chahin, Abdullah [2 ,3 ,4 ]
Buhaish, Abdulrahman
Shorman, Mahmoud [5 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Dept Microbiol, Univ Hlth Network, Toronto, ON, Canada
[2] Brown Univ, Div Infect Dis, Kent Cty Mem Hosp, Providence, RI USA
[3] Brown Univ, Crit Care Div, Kent Cty Mem Hosp, Providence, RI USA
[4] Brown Univ, Alpert Med Sch, Providence, RI USA
[5] Univ Tennessee, Div Infect Dis, Med Ctr, Knoxville, TN 37920 USA
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2020年 / 14卷 / 12期
关键词
COVID-19; Yemen; Coronavirus; Covid-19; pandemic; CLINICAL CHARACTERISTICS;
D O I
10.3855/jidc.13966
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Coronavirus infectious disease 2019 (COVID-19) is currently one of the most important public health crises affecting the global human population. It continues to spread widely, as the world still lacks specific treatments and a vaccine for the virus. The scenario of COVID-19 in Yemen seems obscure due to the lack of adequate data, therefore, we developed an electronic questionnaire and distributed it online among Yemeni people. The aim of this study was to understand the COVID-19 epidemiological situation in Yemen better since there is currently limited published data and limited availability of COVID-19 testing. Methodology: A 34-question web-based survey was distributed on social media outlets targeting people in Yemen. Data aggregation, analysis, and visualization were performed using Tableau and Microsoft Excel. Results: 2,341 individuals reported symptoms concerning for COVID-19 infection, with 25.4% reporting a chronic medical condition. Diabetes, hypertension, asthma, and immune deficiency were associated with increased severity of the disease, while obesity, cardiovascular disease, kidney disease, and liver disease were not. Only 37 individuals (1.6%) had a confirmatory COVID-19 PCR test. The presence of high fever, dyspnea, chest pain, and dysphagia were symptoms that tended to be correlated to worse clinical outcomes. Conclusions: This study provides some important information about the early overspread of COVID-19 within the Yemeni community in May, June, and July of 2020. It shows that online questionnaires may help in collecting data about pandemics in resource-limited countries where testing availability is limited.
引用
收藏
页码:1374 / 1379
页数:6
相关论文
共 50 条
  • [31] COVID-19 and Anemia: What Do We Know So Far?
    Abu-Ismail, Luai
    Taha, Mohammad J. J.
    Abuawwad, Mohammad T.
    Al-Bustanji, Yaqeen
    Al-Shami, Khayry
    Nashwan, Abdulqadir
    Yassin, Mohamed
    HEMOGLOBIN, 2023, 47 (03) : 122 - 129
  • [32] COVID-19 and diabetes: What do we know so far?
    Gangadaran, Prakash
    Padinjarathil, Himabindu
    Rajendran, Shri Hari Subhashri
    Jogalekar, Manasi P.
    Hong, Chae Moon
    Aruchamy, Baladhandapani
    Rajendran, Uma Maheswari
    Gurunagarajan, Sridharan
    Krishnan, Anand
    Ramani, Prasanna
    Subramanian, Kavimani
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (15) : 1330 - 1334
  • [33] COVID-19 and the liver: What do we know so far?
    Nasa, Prashant
    Alexander, George
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (05) : 522 - 532
  • [34] What do we know about Kawasaki disease and COVID-19?
    Alberto Hernandez Arias, Jeffrey James William
    Herrera de la Hoz, Rosa Elena
    Lequerica Segrera, Pedro Luis
    ANDES PEDIATRICA, 2021, 92 (02): : 281 - 287
  • [35] What do we know about business and economics research during COVID-19: a bibliometric review
    Alshater, Muneer M.
    Atayah, Osama F.
    Khan, Ashraf
    ECONOMIC RESEARCH-EKONOMSKA ISTRAZIVANJA, 2022, 35 (01): : 1884 - 1912
  • [36] An Overview of a Year with COVID-19: What We Know?
    Teodorescu, Mirela
    ELECTRONIC JOURNAL OF GENERAL MEDICINE, 2021, 18 (03):
  • [37] COVID-19 and Older Adults: What We Know
    Shahid, Zainab
    Kalayanamitra, Ricci
    McClafferty, Brendan
    Kepko, Douglas
    Ramgobin, Devyani
    Patel, Ravi
    Aggarwal, Chander Shekher
    Vunnam, Ramarao
    Sahu, Nitasa
    Bhatt, Dhirisha
    Jones, Kirk
    Golamari, Reshma
    Jain, Rohit
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (05) : 926 - 929
  • [38] The Effects of COVID-19 on Placenta and Pregnancy: What Do We Know So Far?
    Wong, Yin Ping
    Khong, Teck Yee
    Tan, Geok Chin
    DIAGNOSTICS, 2021, 11 (01)
  • [39] COVID-19 and hepatic damage: what we know?
    Mameli, Simone
    Marcialis, Maria A.
    Bassareo, Pier P.
    Fanos, Vassilios
    PANMINERVA MEDICA, 2023, 65 (01) : 58 - 64
  • [40] What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (01) : 27 - 33